Recent Analysis Shows Microsoft, Alnylam Pharmaceuticals, F5 Networks, Green Plains Partners LP, Itron, and Progress Software Market Influences — Renewed Outlook, Key Drivers of Growth

NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Microsoft Corporation (NASDAQ:MSFT), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), F5 Networks, Inc. (NASDAQ:FFIV), Green Plains Partners LP (NASDAQ:GPP), Itron, Inc. (NASDAQ:ITRI), and Progress Software Corporation (NASDAQ:PRGS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

MSFT DOWNLOAD: http://MarketSourceResearch.com/register/?so=MSFT
ALNY DOWNLOAD: http://MarketSourceResearch.com/register/?so=ALNY
FFIV DOWNLOAD: http://MarketSourceResearch.com/register/?so=FFIV
GPP DOWNLOAD: http://MarketSourceResearch.com/register/?so=GPP
ITRI DOWNLOAD: http://MarketSourceResearch.com/register/?so=ITRI
PRGS DOWNLOAD: http://MarketSourceResearch.com/register/?so=PRGS

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Microsoft Corporation (NASDAQ:MSFT), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), F5 Networks, Inc. (NASDAQ:FFIV), Green Plains Partners LP (NASDAQ:GPP), Itron, Inc. (NASDAQ:ITRI), and Progress Software Corporation (NASDAQ:PRGS) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed December 3rd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

MICROSOFT CORPORATION (MSFT) REPORT OVERVIEW

Microsoft's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Microsoft reported revenue of $29,084.00MM vs $24,538.00MM (up 18.53%) and analysts estimated basic earnings per share $1.15 vs $0.85 (up 35.29%). For the twelve months ended June 30th, 2018 vs June 30th, 2017, Microsoft reported revenue of $110,360.00MM vs $96,571.00MM (up 14.28%) and analysts estimated basic earnings per share $2.15 vs $3.29 (down 34.65%). Analysts expect earnings to be released on January 30th, 2019. The report will be for the fiscal period ending December 31st, 2018. Based on 15 analysts' forecasts, the consensus EPS forecast for the quarter is $0.96. The reported EPS for the same quarter last year was $0.96. The estimated EPS forecast for the next fiscal year is $4.94 and is expected to report on July 18th, 2019.

To read the full Microsoft Corporation (MSFT) report, download it here: http://MarketSourceResearch.com/register/?so=MSFT

-----------------------------------------

ALNYLAM PHARMACEUTICALS, INC. (ALNY) REPORT OVERVIEW

Alnylam Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Alnylam Pharmaceuticals reported revenue of $2.07MM vs $17.10MM (down 87.90%) and analysts estimated basic earnings per share -$2.43 vs -$1.34. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Alnylam Pharmaceuticals reported revenue of $89.91MM vs $47.16MM (up 90.66%) and analysts estimated basic earnings per share -$5.42 vs -$4.79. Analysts expect earnings to be released on February 14th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$1.48. The estimated EPS forecast for the next fiscal year is -$8.33 and is expected to report on February 14th, 2019.

To read the full Alnylam Pharmaceuticals, Inc. (ALNY) report, download it here: http://MarketSourceResearch.com/register/?so=ALNY

-----------------------------------------

F5 NETWORKS, INC. (FFIV) REPORT OVERVIEW

F5 Networks' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, F5 Networks reported revenue of $562.71MM vs $538.00MM (up 4.59%) and analysts estimated basic earnings per share $2.19 vs $2.14 (up 2.34%). For the twelve months ended September 30th, 2018 vs September 30th, 2017, F5 Networks reported revenue of $2,161.41MM vs $2,090.04MM (up 3.41%) and analysts estimated basic earnings per share $7.41 vs $6.56 (up 12.96%). Analysts expect earnings to be released on January 23rd, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $1.83. The estimated EPS forecast for the next fiscal year is $9.09 and is expected to report on October 23rd, 2019.

To read the full F5 Networks, Inc. (FFIV) report, download it here: http://MarketSourceResearch.com/register/?so=FFIV

-----------------------------------------

GREEN PLAINS PARTNERS LP (GPP) REPORT OVERVIEW

Green Plains Partners LP's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Green Plains Partners LP reported revenue of $25.77MM vs $26.45MM (down 2.57%) and basic earnings per share $0.45 vs $0.45 (unchanged). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Green Plains Partners LP reported revenue of $106.99MM vs $103.77MM (up 3.10%) and analysts estimated basic earnings per share $1.85 vs $1.79 (up 3.35%). Analysts expect earnings to be released on February 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.50. The estimated EPS forecast for the next fiscal year is $1.74 and is expected to report on February 6th, 2019.

To read the full Green Plains Partners LP (GPP) report, download it here: http://MarketSourceResearch.com/register/?so=GPP

-----------------------------------------

ITRON, INC. (ITRI) REPORT OVERVIEW

Itron's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Itron reported revenue of $595.96MM vs $486.75MM (up 22.44%) and analysts estimated basic earnings per share $0.51 vs $0.66 (down 22.73%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Itron reported revenue of $2,018.20MM vs $2,013.19MM (up 0.25%) and analysts estimated basic earnings per share $1.48 vs $0.83 (up 78.31%). Analysts expect earnings to be released on February 27th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.01. The estimated EPS forecast for the next fiscal year is $3.38 and is expected to report on February 27th, 2019.

To read the full Itron, Inc. (ITRI) report, download it here: http://MarketSourceResearch.com/register/?so=ITRI

-----------------------------------------

PROGRESS SOFTWARE CORPORATION (PRGS) REPORT OVERVIEW

Progress Software's Recent Financial Performance

For the three months ended August 31st, 2018 vs August 31st, 2017, Progress Software reported revenue of $95.68MM vs $97.31MM (down 1.67%) and analysts estimated basic earnings per share $0.37 vs $0.23 (up 60.87%). For the twelve months ended November 30th, 2017 vs November 30th, 2016, Progress Software reported revenue of $397.57MM vs $405.34MM (down 1.92%) and analysts estimated basic earnings per share $0.78 vs -$1.13. Analysts expect earnings to be released on January 9th, 2019. The report will be for the fiscal period ending November 30th, 2018. The reported EPS for the same quarter last year was $0.60. The estimated EPS forecast for the next fiscal year is $2.15 and is expected to report on January 9th, 2019.

To read the full Progress Software Corporation (PRGS) report, download it here: http://MarketSourceResearch.com/register/?so=PRGS

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: [email protected]

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.